Production (Stage)
American Oncology Network, Inc.
AONC
$6.15
$0.050.82%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 223.11% | -129.52% | 146.18% | -109.09% | -138.27% |
| Total Depreciation and Amortization | 19.29% | -0.96% | 2.82% | 8.83% | 5.88% |
| Total Amortization of Deferred Charges | -100.00% | -16.74% | 0.00% | -0.92% | 0.00% |
| Total Other Non-Cash Items | 87.45% | 158.12% | -33.06% | 69.50% | 40.50% |
| Change in Net Operating Assets | 92.39% | -2.10% | -165.75% | 950.88% | -57.14% |
| Cash from Operations | 142.47% | 17.24% | -175.16% | 477.46% | -207.48% |
| Capital Expenditure | 1.95% | -59.55% | 2.13% | -49.93% | -4.87% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -- | -- | -- |
| Cash Acquisitions | -- | 100.00% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -151.14% | 140.98% | 57.45% | 164.22% | 44.05% |
| Cash from Investing | -214.80% | 975.66% | -212.55% | 114.01% | 40.86% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 1.38% | 33.21% | -1,146.50% | 23.79% | -33.77% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | 100.00% | -3,538.14% | -8.99% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -625.33% |
| Other Financing Activities | -- | -- | -- | -- | -100.04% |
| Cash from Financing | 3,826.93% | 76.18% | -2,059.84% | 13.90% | -124.62% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 401.80% | 65.02% | -188.62% | 300.77% | -9.78% |